Navigation Links
Euthymics Bioscience Collaborates with GlobalSign and SafeNet to Provide an FDA Approved Electronic Signature Solution
Date:2/4/2010

GlobalSign’s digital signature solution and SafeNet’s iKey authenticator provide Euthymics with a streamlined electronic document exchange process.

(PRWEB) February 4, 2010 -- GlobalSign Inc., one of the longest established Certification Authorities (CA) and specialists in Digital Identities for securing PDF documents, has today announced the success of GlobalSign’s digital signature solution, DocumentSign in the pharmaceutical industry. Euthymics, a start-up biotechnology company has implemented a joint GlobalSign and SafeNet solution not only designed to meet the requirements of FDA regulated activities, but to solve Euthymics’ need for a streamlined, improved, and standardized documenting process deploying electronic signatures.

Before the introduction of digital signatures Euthymics, a bio-pharmaceutical company focused on neuroscience, was required to hand-sign documents and manually manage the process of distribution, storage, and retrieval of all signed records. This manual process extended project schedules and deadlines and increased cost due to the overhead of archiving, mailing, and faxing documents. Recognizing the cost and time saving advantages of using electronic signatures over hand signatures, Euthymics required a solution that automated the streamlined exchange of documents from remote locations, and critically complied with Federal Regulations for electronic signatures and electronic records (Title 21 CFR Part 11). Title 21 CFR Part 11 of the Code of Federal Regulations establishes criteria under which electronic records and electronic signatures are considered trustworthy, reliable, and equivalent to paper records.

GlobalSign is an authorized participant in Adobe’s Certified Document Services (CDS) program. Its CDS offering, branded as DocumentSign is a joint solution that incorporates a USB token or PCI crypto card manufactured by S
'/>"/>

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2009 Financial Results
2. Synomics Pharma and Bioscience Laboratories Announce Partnership to Provide Topical Clinical Phase 1 Study Services
3. Therapure Biopharma Inc. and YM BioSciences Inc. Announce Partnership
4. Thriving Bioscience Region Leaves Its Mark
5. HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China
6. Mineral BioSciences to Attend SupplySide West in Las Vegas
7. Sangamo BioSciences Reports Third Quarter 2009 Financial Results
8. Sangamo BioSciences Announces Presentation of Top-Line Statistically Significant Phase 2 Data in Diabetic Neuropathy at Society for Neuroscience Meeting
9. Magellan Biosciences Sells its Life Sciences Tools Business to Dionex
10. Regado Biosciences Announces First Patient Enrolled in RADAR (Phase 2b) Study of REG1 Anticoagulation System
11. Neurocrine Biosciences to Present at the Thomas Weisel Partners Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... need surgery for facial pain caused by trigeminal neuralgia, ... reports a study in the September issue of ... Congress of Neurological Surgeons . The journal is published ... of Wolters Kluwer Health . , Percutaneous stereotaxic ... cost than other types of surgical treatments for trigeminal ...
(Date:8/22/2014)... Key West Health & Beauty’s ( ... much anticipated study results of the 12 best and ... an accompanying infographic on their website. It appears that ... major impact on the skin and contribute to many ... When asked how they determined the results, founder and ...
(Date:8/22/2014)... According to the new research ... Global Trends & Forecast to 2019" defines and ... forecast of the market value. The isocyanate material ... 2019, at a significant CAGR from 2014 to ... 44 figures spread through 286 pages and in-depth ...
(Date:8/22/2014)... 22, 2014 Braverman Eye Center is ... Lauderdale at the most affordable fee. They are on ... their advanced Lasik treatments. LASIK is a highly successful ... Eye Center has been delivering successful LASIK solutions to ... glasses-free and contact lenses-free life with the help of ...
(Date:8/22/2014)... A new study finds a wide range of ... related to key environmental exposuresin children with Crohn,s disease (CD), ... of the Crohn,s & Colitis Foundation of America ... & Wilkins , a part of Wolters Kluwer Health ... alterations of DNA in several regions of the genome in ...
Breaking Medicine News(10 mins):Health News:More common procedures for painful facial tics carry high costs, reports study in Neurosurgery 2Health News:Key West Health & Beauty Announces The 12 Best & Worst U.S. Cities For Skin Study 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 2Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 3Health News:Isocyanate Market An Industry Growing Steadily Projected to Grow $38,729 Million by 2019 - Report by MarketsandMarkets 4Health News:Braverman Eye Center Now Offers Lasik Treatment in Fort Lauderdale at the Most Affordable Fee 2Health News:Study shows epigenetic changes in children with Crohn's disease 2
... associated protein-1 (TRAP-1) may prevent cancer cell death. The ... as a Novel Molecular Target in Localized and Metastatic Prostate ... American Journal of Pathology . Prostate cancer is the ... cause of cancer deaths among men in the United States, ...
... are not as stringent as with new medications , TUESDAY, ... Administration may not be as stringent in evaluating devices as ... report in the Dec. 23/30 issue of the Journal ... often sails through based on studies that are not randomized ...
... stick to your workout routine, even in foul weather , ... chill on even the most enthusiastic exerciser,s plans. It,s hard ... sidestep icy patches. And who wants to go to the ... windshield first? , But sticking to your exercise program throughout ...
... have replaced the street as easy source of medications, experts ... death of pop star Michael Jackson in 2009 drew new ... States. , And with that attention has come acknowledgment ... five teenagers and adults -- about 50 million Americans -- ...
... the lab, expert says , TUESDAY, Dec. 29 (HealthDay ... cause some germs to develop resistance to antibiotics, new ... outside of the laboratory and they don,t suggest that ... "It is OK to use disinfectants. Just don,t misuse ...
... Texas, Dec. 29 Top marketing representatives ... Global Hotel Alliance brand members recently hosted a unique "Lasso ... The luxury hotel brands from across the world readily joined forces ... GHA associate who succumbed to lymphoma cancer in May. ...
Cached Medicine News:Health News:The cancer 'TRAP' 2Health News:Study Questions FDA Approvals of Cardiac Devices 2Health News:Study Questions FDA Approvals of Cardiac Devices 3Health News:Study Questions FDA Approvals of Cardiac Devices 4Health News: Winter Exercise Can Lift Your Spirits 2Health News:In U.S., Prescription Drug Abuse Is Growing 2Health News:In U.S., Prescription Drug Abuse Is Growing 3Health News:In U.S., Prescription Drug Abuse Is Growing 4Health News:Disinfectant Misuse Might Help Germs Resist Antibiotics 2Health News:Disinfectant Misuse Might Help Germs Resist Antibiotics 3Health News:Omni Hotels & Resorts and Global Hotel Alliance Partner for Charity 2Health News:Omni Hotels & Resorts and Global Hotel Alliance Partner for Charity 3
(Date:8/21/2014)... , Aug. 21, 2014   Memorial Hermann Health System ... Center today announced a new partnership to provide a ... community breast care centers in the greater Houston ... Anderson will become the exclusive provider of professional breast radiology ... located in Memorial City, The Woodlands , ...
(Date:8/21/2014)... 21, 2014 Nektar Therapeutics (NASDAQ: ... announced positive results from its Phase 3 pivotal ... half-life recombinant factor VIII (rFVIII) treatment for hemophilia ... met its primary endpoint in reducing annualized bleed ... the on-demand arm. Top-line results from ...
(Date:8/21/2014)... The spinal column is one of the most delicate and ... from the brain through the column control many key functions ... here can be life altering, and leave the victim in ... body. Though back injury and disease can have an intensely ... available to make things better than ever before. Laser ...
Breaking Medicine Technology:Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5Don't Live in Pain: Four Life Improving Benefits of Back Surgery 2
... 6, 2011 NeuroSigma, Inc., a Los Angeles-based ... a notice of award for an NIH Small ... the National Institute of Neurological Disorders and Stroke ... trigeminal nerve stimulation (eTNS™) therapy for the treatment ...
... NEW YORK, Sept. 6, 2011 ... research report is available in its ... Vaccines - Cell Culture Technology Gradually ... http://www.reportlinker.com/p0610894/Manufacturing-of-Vaccines---Cell-Culture-Technology-Gradually-Replacing-Egg-Based-Manufacturing.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication Manufacturing ...
Cached Medicine Technology:NeuroSigma Receives Notice of Award from NIH for an STTR Grant for its Trigeminal Nerve Stimulation Therapy for Epilepsy 2Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing 2Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing 3Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing 4Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing 5Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing 6Manufacturing of Vaccines - Cell Culture Technology Gradually Replacing Egg-Based Manufacturing 7